Chemotherapies may promote tumor immunogenicity either by inducing immunogenic cell death as part of their therapeutic effect or by enhancing tumor antigen presentation or upregulating co-stimulatory molecules/downregulating co-inhibitory molecules expressed on the tumor cell surface, such as PDL-1 [5, 6]. Here, CD274 is linked to neoplasm.